Revisiting the clinical evidence and economics of dexmedetomidine use

Abstract

Get full access to this article

View all access options for this article.

References

Chen

Xin

et al.

Alpha-2 agonists for long-term sedation during mechanical ventilation in critically ill patients. Cochrane Database Syst Rev 2015; 1: CD010269–CD010269.

Ruokonen

Parviainen

Jakob

et al.

Dexmedetomidine versus propofol/midazolam for long-term sedation during mechanical ventilation. Intensive Care Med 2009; 35: 282–290.

Turunen

Jakob

Ruokonen

et al.

Dexmedetomidine versus standard care sedation with propofol or midazolam in intensive care: an economic evaluation. Crit Care 2015; 19: 67–67.

Thoma

McDaniel

et al.

Clinical and economic impact of substituting dexmedetomidine for propofol due to a US drug shortage: examination of coronary artery bypass graft patients at an urban medical centre. Pharmacoeconomics 2014; 32: 149–157.

All Wales Therapeutic and Toxicology Centre. AWMSG Secretariat assessment report: advice no. 2312: dexmedetomidine (Dexdor®) 100 micrograms/ml concentrate foe solution for infusion. Penarth, Wales, UK: All Wales Therapeutics and Toxicology Centre, 2014.

Lachaine

Beauchemin

. Economic evaluation of dexmedetomidine relative to midazolam for sedation in the intensive care unit. Can J Hosp Pharm 2012; 65: 103–110.

Dasta

Kane-Gill

Pencina

et al.

A cost-minimization analysis of dexmedetomidine compared with midazolam for long-term sedation in the intensive care unit. Crit Care Med 2010; 38: 497–503.

Scottish Medicines Consortium. Dexmedetomidine 100 micrograms/mL concentrate for solution for infusion (Dexdor®). Glasgow: SMC, 2012, p.10, www.scottishmedicines.org.uk/files/advice/dexmedetomidine_Dexdor_FINAL_May_2012_for_website.pdf (accessed 2 December 2016).

Athanazio

Maldini

Roa

et al.

Cost-minimisation analysis of dexmedetomidine versus propofol in mechanical ventilated patients at ICU. Value Health 2015; 18: A842–A843.

10.

Patanwala

Erstad

. Comparison of dexmedetomidine versus propofol on hospital costs and length of stay. J Intensive Care Med 2016; 31: 466–470.

11.

Riker

Shehabi

Pencina

et al.

The cost effectiveness of dexmedetomidine vs midazolam in adult ICU patients with prolonged mechanical ventilation: an economic model. Crit Care Med 2008; 36: A17–A17.